National Health Commission: China has started sequential immunization in key areas


This afternoon (February 19), the Joint Prevention and control mechanism of The State Council held a press conference.Wu Liangyou, deputy director of the DISEASE control and Prevention Bureau of the NHC, said at the meeting that the NHC has started to strengthen the sequential immunization with the approval of the Joint prevention and control mechanism of The State Council.Previously, target groups aged 6 months and over 18 who received inactivated vaccines from Sinopac Beijing, Sinopac Beijing, Sinopac Wuhan or adenovirus vector vaccines from Tianjin Concino could receive a single dose of secondary homologous booster immunization, that is, a booster with the original vaccine.After the implementation of the sequential enhanced immunization strategy, the target population that has completed the whole vaccination of the three inactivated vaccines mentioned above can also choose the recombinant protein vaccine of Zhiphirongoma or the adenovirus vector vaccine of Concino for sequential enhanced immunization.For the target population, either homologous booster immunization or sequential booster immunization can be selected.In addition, the Joint prevention and control mechanism of The State Council also approved homologous enhanced immunization of novel Coronavirus inactivated vaccines from Shenzhen Kangtai Company and the Institute of Biology of Chinese Academy of Medical Sciences.Both homologous booster and sequential booster should be implemented in people over 18 years of age who have completed the full course of vaccination for at least 6 months.Research data show that both homologous and sequential strengthening of immunization can further improve the immunization effect. It is hoped that people who meet the vaccination conditions can take the initiative to vaccinate and vaccinate early, so as to improve their health and fuel the epidemic prevention.Source: CCTV News

Leave a Reply

Your email address will not be published.